Join me, Gay Lynn, at the Health and Wellness Social on Saturday, November 7, from noon to 4 PM at Optimize U Ocala.
📍 7502 SW 60th Ave, #B, Ocala
#TreatmentResistantDepression
Join me, Gay Lynn, at the Health and Wellness Social on Saturday, November 7, from noon to 4 PM at Optimize U Ocala.
📍 7502 SW 60th Ave, #B, Ocala
#TreatmentResistantDepression
Link: ift.tt/KJ5eyrO
#TreatmentResistantDepression #PsychedelicTherapy #MentalHealth #Psychotherapy #ClinicalResearch
Link: ift.tt/KJ5eyrO
#TreatmentResistantDepression #PsychedelicTherapy #MentalHealth #Psychotherapy #ClinicalResearch
Call me today at 352-322-2134 to talk about your options, or visit gaylynn.net.
#KetamineTherapy #TreatmentResistantDepression #MentalHealthMatters #OcalaCounseling #GayLynnNet
Call me today at 352-322-2134 to talk about your options, or visit gaylynn.net.
#KetamineTherapy #TreatmentResistantDepression #MentalHealthMatters #OcalaCounseling #GayLynnNet
Spravato® (esketamine) is an FDA-approved nasal spray for adults with treatment-resistant depression, and for adults with major...see more
🌐 Website: www.mybrighterhealth.com
#Spravato #Esketamine #TreatmentResistantDepression
Spravato® (esketamine) is an FDA-approved nasal spray for adults with treatment-resistant depression, and for adults with major...see more
🌐 Website: www.mybrighterhealth.com
#Spravato #Esketamine #TreatmentResistantDepression
Ask us about Spravato® treatment today.
🌐 Website: www.mybrighterhealth.com
#Spravato #SpravatoTreatment #Esketamine #TreatmentResistantDepression
Ask us about Spravato® treatment today.
🌐 Website: www.mybrighterhealth.com
#Spravato #SpravatoTreatment #Esketamine #TreatmentResistantDepression
#TreatmentResistantDepression #MentalHealth #Neurotech #Houston
#TreatmentResistantDepression #MentalHealth #Neurotech #Houston
When depression symptoms continue despite traditional antidepressant treatment, you may have questions about other treatment options.
🌐 mybrighterhealth.com
#Spravato #SpravatoTreatment #Esketamine #TreatmentResistantDepression #DepressionTreatment
When depression symptoms continue despite traditional antidepressant treatment, you may have questions about other treatment options.
🌐 mybrighterhealth.com
#Spravato #SpravatoTreatment #Esketamine #TreatmentResistantDepression #DepressionTreatment
#depression #AEDP #treatmentresistantdepression #mentalhealth
www.hilaryjacobshendel.com/post/2015/06...
#depression #AEDP #treatmentresistantdepression #mentalhealth
www.hilaryjacobshendel.com/post/2015/06...
#TreatmentResistantDepression #Orlando
www.rawstory.com/these-florid...
#TreatmentResistantDepression #Orlando
www.rawstory.com/these-florid...
#MentalHealthAwareness #TreatmentResistantDepression #Spravato
#MentalHealthAwareness #TreatmentResistantDepression #Spravato
There are DOZENS of effective next-step treatments: tDCS, TMS, ketamine/esketamine, ECT, augmentation strategies, etc. Many of them go into full remission after being labeled “treatment resistant.”👏
#TreatmentResistantDepression #MentalHealth
There are DOZENS of effective next-step treatments: tDCS, TMS, ketamine/esketamine, ECT, augmentation strategies, etc. Many of them go into full remission after being labeled “treatment resistant.”👏
#TreatmentResistantDepression #MentalHealth
#MentalHealthCare #Spravato #Esketamine #TreatmentResistantDepression #OPMHS #Hope #MentalWellness
#MentalHealthCare #Spravato #Esketamine #TreatmentResistantDepression #OPMHS #Hope #MentalWellness
#psilocybin #psychedelicscience #treatmentresistantdepression
#psilocybin #psychedelicscience #treatmentresistantdepression
#KetamineTherapy #TreatmentResistantDepression
👇 Learn More:
#KetamineTherapy #TreatmentResistantDepression
👇 Learn More:
#depression #mentalhealth #mentalillness #TMS #esketamine #ECT #psychiatrist #psychologist #treatmentresistantdepression
#depression #mentalhealth #mentalillness #TMS #esketamine #ECT #psychiatrist #psychologist #treatmentresistantdepression
Read for strategy, not slogans 📘➡️ doi.org/10.3390/biom...
Read for strategy, not slogans 📘➡️ doi.org/10.3390/biom...
It drives disability, costs, and service pressures.
Yet effective add-on treatments are underused.
🧵 THREAD
#DifficultToTreatDepression #TreatmentResistantDepression #MentalHealthPolicy
It drives disability, costs, and service pressures.
Yet effective add-on treatments are underused.
🧵 THREAD
#DifficultToTreatDepression #TreatmentResistantDepression #MentalHealthPolicy
20–50% of patients with depression meet criteria for treatment-resistant depression.
Evidence-based options exist, but are underused.
The LQD study tested lithium vs quetiapine as augmentation.
🧵 THREAD #TreatmentResistantDepression
buff.ly/Zvza0o1
20–50% of patients with depression meet criteria for treatment-resistant depression.
Evidence-based options exist, but are underused.
The LQD study tested lithium vs quetiapine as augmentation.
🧵 THREAD #TreatmentResistantDepression
buff.ly/Zvza0o1
About half of people still have symptoms, even after more than one medication.
🧵 THREAD
#DifficultToTreatDepression #TreatmentResistantDepression
buff.ly/BtJ3ydR
About half of people still have symptoms, even after more than one medication.
🧵 THREAD
#DifficultToTreatDepression #TreatmentResistantDepression
buff.ly/BtJ3ydR